T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
PRWCX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 30, 2014 at 4pm EST
Fund Composition
Asset Allocation
as of 04/30/2016
Domestic Stock 56.8%
Domestic Bond 19.3%
Cash 17.0%
Foreign Bonds 4.2%
Foreign Stock 1.5%
Convertibles 1.1%
Preferreds 0.9%
Options -0.3%
Volatility and Other Measures
as of 04/30/2016
Beta 0.63
0.94
Standard Deviation 7.32
Price/Earnings Ratio (Domestic) 18.2
Earnings Growth Rate (Domestic) 11.1
Turnover Rate 18.6
Median Market
Capitalization
$43,298.25 Million
Sector Diversification
as of 04/30/2016
% of Total Net Assets
Health Care 15.7%
Financials 13.3%
Industrials & Business Services 9.1%
Information Technology 8.8%
Consumer Discretionary 6.0%
Consumer Staples 3.7%
Utilities 1.6%
Energy 0.7%
Telecommunication Services 0.5%
10 Largest Holdings
Represents 25.34 % of Total Net Assets
View Holdings as of:
Abbott Laboratories
Bank of New York Mellon
Becton, Dickinson & Company
Danaher
Marsh & McLennan
Microsoft
Pfizer
Thermo Fisher Scientific
Tyco International
Willis Group Holdings
As of 04/30/2016 the Capital Appreciation Fund had a total of 257 holdings.
See Glossary for additional details on all data elements.